Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.

Dr. Barry Dworkin

Medical Mythbusting Commentary for February 3, 2021

Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can't do it. Play Now | Play in Popup | Download

Source:
Myths of Vaccine Manufacturing
A vial, a vaccine and hopes for slowing a pandemic — how a shot comes to be
Why Even Presidential Pressure Might Not Get More Vaccine to Market Faster

Reference:
Exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 vaccines

Related posts:

  1. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  2. New biotherapeutic cancer treatment centre an excellent addition to novel therapeutic solutions
  3. Logistics of distributing mRNA vaccines (if approved) will be problematic. Excellent article in @TheAtlantic explains why.
  4. The 10,000 steps: Marketing myths that make reality in its own self-interested image
Bitnami